Search
for
Sort by
Research 181–210 of 1000+
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Androgen excess is the key element in polycystic ovary syndrome
- Polycystic ovary syndrome and impact on health
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Therapeutic Androgen Receptor Ligands
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist
- Secondary amenorrhea
- Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
- Clinical use of 5α-reductase inhibitors
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Diagnosis and treatment of polycystic ovarian syndrome: an update
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Polycystic Ovarian Syndrome - What is New
- Molecular genetics of androgen insensitivity
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- A Review on PCOD: Polycystic Ovarian Disease
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Changes of androgens levels in menopausal women
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Congenital adrenal hyperplasia
- Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome